BCL2 and leukemia: Furthermore, agents with known anti-leukemia activity, e.g. steroids, proteasome, and HDAC inhibitors, but also BCL-2 and cIAP antagonists or tyrosine kinase inhibitors also emerged with potent anti-leukemia activity (Supplementary Fig. S1A, B).